Connect with us
Cancer Occurrence To Surge To 77 % By 2050

Global Cancer Occurrence To Surge To 77 % By 2050, Says UN

More Videos

Published

on

Global Cancer Occurrence To Surge To 77 % By 2050, Says UN—-Global cancer cases are expected to rise around 77 per cent by the middle of the century, UN health authorities said on Thursday.

According to latest figures from the International Agency for Research on Cancer (IARC), a specialised branch of the UN World Health Organisation (WHO), there are predicted to be more than 35 million cancer cases during 2050, up from the estimated 20 million in 2022.

The increase reflects both population ageing and growth, as well as changes to people’s exposure to risk factors which include tobacco, alcohol and obesity are key factors, along with air population.

Richer countries are expected to have the greatest absolute increase in cancer, with an additional 4.8 million new cases predicted in 2050.

However, low and middle-income countries should see a higher proportional increase in cancer, while mortality is projected to almost double.

The estimates from the IARC’s Global Cancer Observatory are based on the best sources of data available from 185 countries and covers 36 different forms of cancer.

They were published alongside a WHO survey from 115 countries which showed that the majority do not adequately finance priority cancer and palliative care services as part of universal health coverage.

Ten types of cancer collectively comprised around two-thirds of new cases and deaths globally in 2022, the IARC said.

Lung cancer was the most commonly occurring form worldwide with 2.5 million new cases.  It accounted for more than 12 per cent of all new cases and 18.9 per cent of deaths, 1.8 million, making it the leading cause of cancer death.

Female breast cancer ranked second in terms of occurrence, with 2.3 million cases, worldwide or 11.6 per cent, but accounted for 6.9 per cent of deaths.

Other commonly occurring cancers were colorectal, prostate and stomach cancer.

Colorectal cancer was the second leading cause of cancer death, followed by liver, breast and stomach cancer.

Cervical cancer was the eighth most commonly occurring cancer globally, the ninth leading cause of cancer death, and the most common cancer in women in 25 countries, many of which are in sub-Saharan Africa.

The IARC estimates – issued ahead of World Cancer Day on February 4 – also revealed striking inequalities, particularly in breast cancer.

One in 12 women in richer countries will be diagnosed with the disease in their lifetime and one in 71 will die of it, the agency said.

However, although only one in 27 women in poorer countries will receive a positive breast cancer diagnosis, one in 48 will die.

These women “are at a much higher risk of dying of the disease due to late diagnosis and inadequate access to quality treatment,” Dr. Isabelle Soerjomataram, Deputy Head of the Cancer Surveillance Branch at IARC, said.

The WHO survey also revealed significant global inequities in cancer services. For example, higher income countries were up to seven times more likely to include lung cancer-related services in their health benefits packages.

“WHO, including through its cancer initiatives, is working intensively with more than 75 governments to develop, finance and implement policies to promote cancer care for all,” Dr Bente Mikkelsen, Director of its Department of Noncommunicable Diseases, said, underlining the need for greater investment.

Facebook 0 Twitter 0 LinkedIn WhatsApp 0Shares
Continue Reading
Click to comment

Leave a ReplyCancel reply

News

EL-Lab Medical Diagnostics And Research Centre Secures ReAccreditation To ISO 15189:2022

Published

on

EL-Lab Medical Diagnostics And Research Centre Secures ReAccreditation To ISO 15189:2022

 

EL-Lab, a leading Medical diagnostic centre in Lagos earns renewed Accreditation from the Nigeria National Accreditation System (NiNAS), affirming its continued technical competence in medical laboratory testing.

 

A medical diagnostic centre with branches across Lagos, EL-Lab is the First Indigenous medical laboratory in Nigeria to attain the ISO 15189 status in Nigeria ten years ago. Till date, Nigeria may have less than 50 medical laboratories in both public and private categories to meet this standard.

 

EL-LAB has maintained this accreditation status for ten (10) years and currently holds this qualification from two (2) accreditation bodies in Nigeria, namely Medical Laboratory Council of Nigeria (MLSCN) and Nigeria National Accreditation System (NiNAS)

 

This achievement of reaccreditation and transition to ISO 15189:2022 for Medical testing, following a rigorous reassessment by Nigeria National Accreditation System (NiNAS) confirms that EL-Lab continues to meet the requirements of ISO 15189:2022, the internationally recognised standard governing quality and competence in medical laboratories. It sets out requirements covering everything from sample handling and testing procedures to staff competence and quality management, giving patients, clinicians, and partner institutions confidence in the accuracy and reliability of results.

 

For a medical diagnostic laboratory, reaccreditation is no small feat. It requires laboratories to demonstrate, through an independent and thorough assessment, that its systems, processes, and personnel consistently deliver results in line with international best practice. NiNAS, as Nigeria’s national accreditation body, conducts these assessments to ensure that accredited laboratories maintain the standards necessary for both local and global recognition.

 

By retaining this accreditation, EL Lab reinforces its position as a trusted provider of medical testing services within Lagos and the broader Nigerian healthcare system.

 

Speaking on this, the Managing Director of EL-Lab, Dr Elochukwu Adibo mni said; “This achievement reflects the laboratory’s commitment to quality assurance, staff training, and process improvement, factors that lead to more reliable outcomes for patients and referring clinicians”.

 

For more information about EL-Lab Medical Diagnostics, visit their website:  https://el-lab.org/

 

 

Facebook 0 Twitter 0 LinkedIn WhatsApp 0Shares
Continue Reading

News

Sri Lanka on Alert as Nipah Virus Cases Emerge in Eastern India

Published

on

Sri Lanka on Alert as Nipah Virus Cases Emerge in Eastern India—-Sri Lanka has stepped up monitoring measures following reports of a Nipah virus cluster in India’s eastern state of West Bengal.

Health authorities across parts of Asia have also heightened vigilance over the emerging situation, the Daily Mirror reported.

Health officials said Sri Lanka is tracking developments at the regional level and remains in contact with international health monitoring systems.

While no cases have been reported locally, authorities have indicated that preparedness measures are in place should the situation evolve.

The alert follows confirmation by Indian authorities of at least five Nipah virus infections in West Bengal, including cases among healthcare workers.

The development has prompted several countries in the region to strengthen preventive measures, particularly at international airports.

Nipah virus is a zoonotic disease transmitted between animals and humans and, in some instances, through human-to-human contact.

It is classified as a priority pathogen by the World Health Organisation due to its epidemic potential and the severity of illness it can cause. Past outbreaks of the Nipah virus have been associated with high fatality rates, ranging from 40 per cent to 75 per cent. (Xinhua/NAN)

Facebook 0 Twitter 0 LinkedIn WhatsApp 0Shares
Continue Reading

Trending

Facebook 0 Twitter 0 LinkedIn WhatsApp 0Shares